Psyomics, a Cambridge, UK-based healthtech company, raised £2.4M in funding.
The round was led by Parkwalk, with participation from Meltwind and Newable Ventures.
The company intends to use the funds to continue to expand access to its online mental health assessment platform to individual users and NHS trusts.
Co-founded by Professor Sabine Bahn, head of the Cambridge Centre for Neuropsychiatric Research (CCNR) and Daniel Cowell, former COO of Horizon Discovery, Psyomics is developing technology to improve the way mental health conditions are assessed and triaged. Its digital diagnostic support platform, called Censeo, mirrors the rich process of a comprehensive face-to-face assessment, in a digital form. Users are guided through a series of adaptive questions to build a detailed picture of their mental health symptoms and concerns. A report that is composed of potential conditions and next step recommendations is then generated, providing patients a stigma-free way to begin addressing any concerns.
When used within a healthcare setting, the platform supports clinicians (whether they are psychiatrists or not) with efficient decision making, helping them to establish the right care pathway and level of support more quickly. A pilot within GP practices was conducted last year, with positive feedback received from both GPs and patients. Following this, access to Censeo was opened up to individual users for the first time earlier this year and new projects within NHS treatment providers are starting.
Psyomics was spun-out from the University of Cambridge.